JPRN-UMIN000008689已完成1 期
A clinical study on safety and efficacy of sorafenib as maintenance chemotherapy after percutaneous isolated hepatic perfusion chemotherapy (PIHP) for advanced hepatocellular carcinoma - A safety and efficacy of sorafenib as maintenance chemotherapy after percutaneous isolated hepatic perfusion (PIHP) for advanced hepatocellular carcinoma
Department of hepato-biliary-pancreatic surgery, Kobe University0 个研究点目标入组 30 人开始时间: 2012年9月19日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with a history of molecular- target therapy including sorafenib. 2)Patients with a history of hypersensitivity of sorafenib 3)Patients who are pregnant or on nurse. 4)Patients who are on dialysis 5)Patients with uncontrolled hypertension 6)Patients with a history of thrombosis, embolism, or ischemic Heart Disease 7)Patients with brain metastasis 8)Patients with esophageal varix with bleeding tendency 9)Patients with gastrointestinal bleeding within one month 10)Patients with ongoing or history of hepatic encephalopathy 11)Patients who undergo rifampin 12)Patients with HIV or AIDS 13)Patients with synclonous double cancer
研究者
相似试验
招募中
不适用
Evaluation of the safety and efficacy of sorafenib therapy after TACE for unresectable hepatocellular carcinoma (multicenter study)Hepatocellular carcinomaJPRN-UMIN000006475Kagoshima University Medical and Dental Hospital70
尚未招募
不适用
Efficacy and Safety of Sorafenib in Previously treated Advanced Hepatocellular Carcinoma: SOPT studyNeoplasmsKCT0006739ational Cancer Center50
尚未招募
2 期
Treatment of Constipation(Qabz) naturally with Safoof-i-Banafsha a unani remedyCTRI/2024/06/068794uqman Unani Medical College Hospital and Research Centre
进行中（未招募）
1 期
An exploratory study of sorafenib for patients listed for transplantation due to HCCPatients >18 years with hepatocellular carcinoma, on waiting list for liver transplantationMedDRA version: 12.1Level: LLTClassification code 10019829Term: Hepatocellular carcinoma recurrentMedDRA version: 12.1Level: LLTClassification code 10019830Term: Hepatocellular carcinoma resectableEUCTR2010-024306-36-SEVästra Götalandsregionen21
进行中（未招募）
不适用
Study on the safety of administration of sevoflurane for long-term sedation in critical patients on assisted ventilation.EUCTR2011-002555-34-ESFRANCISCO JAVIER BELDA